10 20 30 40 50 60 70 80 1BZV - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER HORMONE 04-NOV-98 1BZV
TITLE [D-ALAB26]-DES(B27-B30)-INSULIN-B26-AMIDE A SUPERPOTENT TITLE 2 SINGLE-REPLACEMENT INSULIN ANALOGUE, NMR, MINIMIZED TITLE 3 AVERAGE STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630
KEYWDS INSULIN, SUPERPOTENCY, HORMONE
EXPDTA SOLUTION NMR
AUTHOR G.KURAPKAT,M.SIEDENTOPF,H.G.GATTNER,M.HAGELSTEIN, AUTHOR 2 D.BRANDENBURG,J.GROTZINGER,A.WOLLMER
REVDAT 2 24-FEB-09 1BZV 1 VERSN REVDAT 1 18-MAY-99 1BZV 0
JRNL AUTH G.KURAPKAT,M.SIEDENTOP,H.G.GATTNER,M.HAGELSTEIN, JRNL AUTH 2 D.BRANDENBURG,J.GROTZINGER,A.WOLLMER JRNL TITL THE SOLUTION STRUCTURE OF A SUPERPOTENT JRNL TITL 2 B-CHAIN-SHORTENED SINGLE-REPLACEMENT INSULIN JRNL TITL 3 ANALOGUE. JRNL REF PROTEIN SCI. V. 8 499 1999 JRNL REFN ISSN 0961-8368 JRNL PMID 10091652
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISTANCE GEOMETRY GEOMETRY REMARK 3 AUTHORS : SCHEEK REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1BZV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 2.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 16 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: MEAN STRUCTURE.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE B 1 CB - CG - CD2 ANGL. DEV. = -4.7 DEGREES REMARK 500 PHE B 25 CB - CG - CD2 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 2 -155.29 65.67 REMARK 500 VAL A 3 -71.60 -14.84 REMARK 500 SER A 9 -135.16 -137.13 REMARK 500 CYS A 11 -71.59 -39.61 REMARK 500 SER A 12 147.50 98.40 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1BZV A 1 21 UNP P01312 INS_BALPH 31 51 DBREF 1BZV B 1 25 UNP P30410 INS_PANTR 25 49
SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE DAL
HET DAL B 26 5
HETNAM DAL D-ALANINE
FORMUL 2 DAL C3 H7 N O2
HELIX 1 H1 ILE A 2 THR A 8 1 7 HELIX 2 H2 LEU A 13 TYR A 19 1 7 HELIX 3 H3 SER B 9 CYS B 19 1 11
SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.04 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.04
LINK N DAL B 26 C PHE B 25 1555 1555 1.33
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000